2.80
-0.12(-4.11%)
Currency In USD
| Previous Close | 2.92 |
| Open | 2.96 |
| Day High | 2.99 |
| Day Low | 2.74 |
| 52-Week High | 3.5 |
| 52-Week Low | 0.13 |
| Volume | 671,107 |
| Average Volume | 941,537 |
| Market Cap | 212.11M |
| PE | -3.94 |
| EPS | -0.71 |
| Moving Average 50 Days | 1.56 |
| Moving Average 200 Days | 0.7 |
| Change | -0.12 |
If you invested $1000 in The Oncology Institute, Inc. (TOI) since IPO date, it would be worth $288.66 as of May 10, 2025 at a share price of $2.8. Whereas If you bought $1000 worth of The Oncology Institute, Inc. (TOI) shares 3 years ago, it would be worth $424.89 as of May 10, 2025 at a share price of $2.8.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates
GlobeNewswire Inc.
May 08, 2025 12:00 PM GMT
CERRITOS, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI)(“TOI”), one of the largest value-based oncology groups in the United States, announced today that it has been selected to present an abstract at the upcom
The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call
GlobeNewswire Inc.
Apr 23, 2025 12:00 PM GMT
CERRITOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2025 financ
The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials
GlobeNewswire Inc.
Apr 22, 2025 8:05 PM GMT
CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), a pioneer in value-based community oncology care, is proud to announce an enterprise-wide expansion of its strategic partnersh